{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-335047","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2026-08-05T20:05:56+00:00","discovered_at":"2026-08-05T20:07:00.324022+00:00","generated_at":"2026-08-05T20:08:00.207002+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Weight Watchers Q2 revenue $162.3M, clinical subscribers up 55.7% YoY; reaffirms FY guidance","bullets":["Q2 revenue $162.3M (down 14% YoY); clinical subscription revenue $39.9M, up 30.4% YoY.","End-of-period clinical subscribers 197K (+55.7% YoY); Core+ subscribers 541K (+13.9% YoY), third consecutive sequential growth.","Q2 net income $14.1M; Adjusted EBITDA $39.8M; operating cash flow $24.3M.","Reduced term loan principal by $41.4M via $36.8M cash prepayment; cash balance $101.5M.","Reaffirms FY2026 guidance: revenue $620-635M, Adjusted EBITDA $105-115M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-335047","json":"https://secwatch.observer/filing/0001193125-26-335047.json","markdown":"https://secwatch.observer/filing/0001193125-26-335047.md","text":"https://secwatch.observer/filing/0001193125-26-335047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312526335047/0001193125-26-335047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312526335047/d15116d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:08:00.207002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}